C O R P O R A T E P R E S E N T A T I O NAPRIL 2018

C$ RQB

U$ RVVQF

€ 1 IT

This presentation contains forward-looking statements. These forward-looking statements are not based on historical facts but rather on company

expectations regarding future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and

sources of funding thereof), competitive advantages, Business prospects and opportunities. Statements in this presentation about future plans and

intentions, results, level of activity, performance, goals or achievements or other future events constitute forward-looking statements. Wherever

possible, words such as “anticipate:, “believe”, “expect”, “may”, “could”, “will”, “forecast”, “potential”, “intend”, “estimate”, “should”, “plan”,

“predict”, or the negative or other variations of statements reflects managements’ current beliefs and assumptions and are based on information

currently available to the Company management. Certain risk factors may cause actual results, level of activity, performance or achievements to

differ materially from those implied by forward-looking statements. These factors should be considered carefully and prospective investors should not

place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this presentation are based upon

what the Company management believes to be reasonable assumptions, investors cannot be assured that actual results will be consistent with these

forward-looking statements. These forward-looking statements are made as of the date of this presentation and the Company assumes no obligation

to update or revise them to reflect new events or circumstances.

F O R W A R D L O O K I N G S T A T E M E N T

2

A $7.8 Billion Market by 2021T H E O P P O R T U N I T Y

Medical and recreational Cannabis Sectors will generate annual

revenues of $1.8 billion and $6 billion respectively by 20211

1 Cannacord Genuity

700,000 kg supply shortfall in 20182

T H E O P P O R T U N I T Y

Combined 2018 demand will be 1 million kg of Canabis, while supply will be about 300,000 kg, Representing a near-term annual supply shortfall of 700,000 kg. We expect demand will continue to increase for several years.

This represents a huge opportunity for producers who are currently or about to become licensed to produce.2 Health Canada

1,000,000 kgD E M A N D

300,000 kgS U P P L Y

M E D I C A L M A R K E T

• The number of patients is growing at approximately

30% per quarter3

• Licensed producers are contributing to growth of the

market through• Increased attendance at medical industry conferences

• Individual physician engagement

• development of cannabis-specific continuing medical education

programs

3 Health Canada

O V E R A L L M A R K E T S I Z E

• Recreational sales in Canada may reach $6

billion by 20214 as the legal market is replaced

with the regulated adult use market

• Patients in Canada will consume more than

150,000 kg of medical cannabis by the year 2021,

Which could equate to $1.8 billion in retail sales4

• Base retail cannabis market in Canada is

estimated to be between $4.9 billion and $8.7

billion.5

4 Cannacord Genuity Group Inc.5 Deloitte – Recreational Marijuana Insights and Opportunities

G E O R G E R O B I N S O N

• Highest level adviser and consultant to multiple licensed cannabis producers

since the MMPR (predecessor to the ACMPR) was introduced in 2013

• Instrumental in helping a lengthy list of producers meet and/ or maintain

the rigorous standards of compliance set out by Health Canada

• Seen by many as visionary with an in-depth understanding of the

myriad aspects of this emerging industry: facility design, product

safety & efficiency, market acceptance & development, product

evolution

R Q B ’ S T W O D I S T I N C T D I V I S I O N S

SERVICES DIVISION: ESTABLISHED

• Key adviser to extensive and reputable list of clients

• End-to-end solution provider for existing LPs and late-stage

applicants

• Facility design, construction

• Proprietary, industry-leading growing and drying

technologies

INVESTMENT DIVISION

• Westetrn AgriPharma 125,000 sq foot facility planned:25,000

kg year

• FM 468 250,000 sq foot facility planned: 15,000 kg/year

• Bloomera 20,000 sq foot Licensed facility: 4,000 kg/year

• AGB 35,500 sq foot, 7,000 kg/year production facility

completed mid-2018

• 11,000 kg/year production by late 2018

• Strategically positioned for expansion due to consultancy

relationships

• Focus on partnerships with Indigenous Peoples

I N V E S T M E N T D I V I S I O N

Bloomera: Markham, Ontario

• 20,000 square foot Licensed Producer; 2,200 kg current production

• 4,000 kg capacity with Orbital Garden grow technology

I N V E S T M E N T D I V I S I O N

Alberta Green Biotech: Edmonton, Alberta

• 35,500 square foot Edmonton facility currently under construction

• 7,000 kg capacity

• Additional land to expand the facility to more than double capacity as a second stage

• Completion of facility targeted at mid 2018

I N V E S T M E N T D I V I S I O N

Western AgriPharma Limited: Port Mellon, British Columbia (Sunshine Coast) (MOU)

• 125,000 square foot facility, purpose built, 100% interest

• 25,000 kg capacity

I N V E S T M E N T D I V I S I O N

Fort McMurray First Nation #468: Fort McMurray, Alberta (MOU)

• 250,000 square foot facility, purpose built, 30% interest

• 50,000 kg capacity

I N V E S T M E N T D I V I S I O N

FULL CAPACITY AT BUILDOUT = 51,000 KG / YEAR

CONTINUED EXPANSION AHEAD

P R O P R I E T A R Y I N D U S T R Y - L E A D I N G T E C H N O L O G YAutomated Orbital Garden 2.0 can double existing yield standards

I N D I G E N O U S P E O P L E S P A R T N E R S H I P S

• Bill Robinson leads Government/ Indigenous Relations and Strategic Partnerships

• 34 years with RCMP, retired as commanding officer “D” Division

• Former President and CEO, Alberta Gaming & Liquor Commission (AGLC) - Alberta Gaming and Liquor Commission

will serve as the central wholesaler for all cannabis product sold in Alberta

• Extensive relationships with Indigenous Peoples across Canada

• Favorable taxation regime for facility construction, cannabis production & sale on sovereign

Indigenous lands

• Healthy pipeline of engagements with Indigenous Peoples

• Contract to build 24,000 square foot facility for Fort McMurray First Nation #468 announced

November 2017

I N D I G E N O U S P E O P L E S C A N N A B I S A S S O C I A T I O N

• Works collectively with Indigenous Communities across the country. The association coordinates business

opportunities for its members by speaking with one voice to the Government of Canada surrounding Medical

Marijuana production

• Presents a united voice for Indigenous Cannabis Producers across Canada when interacting with federal and

provincial government bodies

• Provides a clearing house for new ideas related to the Indigenous production and sale of cannabis coast to

coast to coast

I N D I G E N O U S P E O P L E S P A R T N E R S H I P S

• Land assessment, zoning, geotechnical

• Step-by-step guidance through the complex Health Canada application process

• Facility design, construction, and security

• Plant genetics

• Proprietary growing, drying, monitoring technologies

RQB’S TURN KEY CANNABIS SOLUTION:

S E R V I C E S D I V I S I O N : I N D U S T R Y E X P E R T I S E

• Delivers comprehensive, integrated solutions to companies in the

regulated cannabis market in Canada

• Proprietary, automated systems for growing, drying, monitoring

designed specifically for cannabis yield maximization

• Unmatched industry best practices

C O M P L I A N C E

• Compliance with Health Canada regulations will be a key determinant of success and profitability

• Proprietary growing and drying technologies, patient engineering management systems, and security systems

ensure compliance which will be unsurpassed in the cannabis industry, greatly reducing risk of shutdowns or

recalls

I N D U S T R Y D I S R U P T I V E R & D

• RavenQuest BioMed recently announced a landmark research

partnership with McGill University

• The work will be conducted through collaboration between two

McGill laboratories

• Dr. Donald Smith - patented technologies for improvement of crop

yields

• Dr. Mark Ware - medical cannabis researcher; Director of clinical

research at the Allen Edwards Pain Management Unit at the McGill

University Health Center (MUHC)

F O U R P I L L A R S A P P R O A C H

IndigenousPeoples

Partnerships

Investment Division

51,000 kg / yrat buildout

Expansion pipeline is full

Services Division

Immediate Revenue

Cash Flow Positive

Deal flow for Investment Division

Scientific Leadership

R&D Initiatives

Partnered with McGill University

M A R K E T R E C E P T I O N

GEORGE ROBINSONCEO & Director

• Recognized specialist in the cannabis sector and has worked directly with the CL2G Group’s

clients and health Canada in all stages of the application and licensing process under the

ACMPR and its predecessor legislation, the MMPR

• Extensive experience in building design, municipal bylaw compliance, heating, ventilation

and air conditioning, cannabis growing and drying strategies, security, data collection and

analysis, and project funding

• B.C. Licensed security consultant, Black Belt Six Sigma certified and current president of the

BC Regional Council of the Canadian Security Association

E X E C U T I V E T E A M

DAVID CROSSCPA, CGA, Chief Financial Officer

• 20 years of public practice with cross Davis and Company, LLP

• CFO of numerous TSX and TSXV issuers

MARLA RITCHIECorporate Secretary

• 25 years of public markets expertise

BILL ROBINSONManager, Government & Indigenous Relations

• 34 years RCMP, Retired Commander “D” division

• Former President & CEO, Alberta Gaming & Liquor Commission

BENILDA SABLEManager, Quality Assurance

• Sought after industry consultant for major Hemp growers and

processors in Canada and worldwide

• Advisor to major Hemp processing facilities domestically and

abroad

B O A R D O F D I R E C T O R S

CHRIS BECHTEL Director

• Over 30 years experience, as an executive, entrepreneur and consultant,

managing and advising businesses from startups to divisions of large

Fortune 500 companies

• Form and chairman of Supreme Pharmaceuticals, Inc., one of first

Canadian public companies in the cannabis sector

TONY DRESCHER CPA, CMA, Director

• Over 35 years experience as an executive and in various industries

including mining, telecommunications, technology and waste

management

• Currently serves on the Board of Directors of several private and public

companies

DR. JORGE BONET Director

• Director of the Atrial Fibrillation Clinic at The Royal Columbian Hospital

• Received international awards for original research as well as grand support

from major foundations

• Principal investigator in multiple major international randomized clinical

studies

HENDRIK (HENK) VAN ALPHEN Director

• Proven leader with experience in funding, building and operating numerous

companies in the resource sector

• Extensive experience in international mergers & acquisitions

• Has been involved in financing and transactions totaling well over $1 billion

in his career

• Canadian public companies experience - has held the executive

management and board positions with multiple issuers

Shares Issued and Outstanding

Share Price (March 2018)

Market Capitalization

92,796,832

C$1.16

C$107 Million

• 51,000 kg of industry-leading technological grow capacity at full buildout

• Experience management team who are recognized leaders in the cannabis industry

• Unique, two-pronged business model diversifies risk

• Assets generating cash flow today

• End-to-end solutions for cannabis industry

• Business model is not reliant on timing of recreational market rollout

• Large and growing market - not creating demand but transferring from illicit to legal

• Strong shareholder base and access to capital for growth

I N V E S T M E N T H I G H L I G H T S

T H A N K Y O U

Mathieu McDonald

Corporate CommunicationsRavenquest BioMed Inc.

Suite 2300 – 1177 West Hastings Street, Vancouver BC, Canada, V6E 2K3

604-484-1230 | mathieu.macdonald@rqbglobal.com